## 14. Share-based compensation

The expense recognized in the interim condensed consolidated statement of operations for share-based compensation is as follows:

### Three months ended September 30,

|  | 2024 | 2023 |
|---|---|---|
| Cost of revenue | 1 | 2 |
| Research and development | 36 | 51 |
| Sales and marketing | 14 | 17 |
| General and administrative | 12 | 15 |
| **Total** | **63** | **85** |

### Nine months ended September 30,

|  | 2024 | 2023 |
|---|---|---|
| Cost of revenue | 5 | 5 |
| Research and development | 122 | 176 |
| Sales and marketing | 48 | 58 |
| General and administrative | 39 | 48 |
| **Total** | **213** | **287** |

Activity in the Group's RSUs and other contingently issuable shares outstanding and related information is as follows:

| RSUs | | Other | |
|---|---|---|---|
| **Number of RSUs** | **Weighted average grant date fair value (US$)** | **Number of Awards** | **Weighted average grant date fair value (US$)** |
| Outstanding at January 1, 2024 | 2,554,925 | 132.39 | 36,898 | 155.83 |
| Granted | 714,326 | 269.56 | | |
| Forfeited | (110,491) | 153.51 | (14,596) | 154.15 |
| Relaunched | 869,041 | 154.39 | | |
| **Outstanding at September 30, 2024** | **2,290,711** | **165.79** | **22,302** | **156.93** |

Activity in the Group's stock options outstanding and related information is as follows:

| Options | |
|---|---|
| **Number of options** | **Weighted average exercise price (US$)** |
| Outstanding at January 1, 2024 | 12,429,245 | 165.93 |
| Granted | 634,058 | 277.16 |
| Forfeited | (236,122) | 155.48 |
| Exercised | (4,319,390) | 159.58 |
| Expired | (193,669) | 309.61 |
| **Outstanding at September 30, 2024** | **8,314,122** | **174.66** |
| Exercisable at January 1, 2024 | 5,793,791 | 184.98 |
| Exercisable at September 30, 2024 | 3,511,066 | 197.31 |

The weighted-average contractual life for the stock options outstanding at September 30, 2024 was 2.7 years. The weighted-average share price at exercise for options exercised during the nine months ended September 30, 2024 was